Description

EFUBAC-TZ 1.125 INJECTION (CEFOPERAZONE 1000MG + TAZOBACTAM 125MG) marketed by Medroots Biopharma Pvt Ltd: EFUBAC-TZ 1.125 is a combination injectable antibiotic manufactured and marketed by Medroots Biopharma Pvt Ltd. This formulation combines two key active pharmaceutical ingredients: Cefoperazone (1000mg): This is a third-generation cephalosporin antibiotic. Tazobactam (125mg): This is a beta-lactamase inhibitor. Mechanism of Action: Cefoperazone (Antibiotic): Class: Cephalosporin. How it works: Cefoperazone works by inhibiting the synthesis of the bacterial cell wall. Bacteria have a rigid cell wall that protects them and maintains their shape. Cefoperazone interferes with the enzymes (penicillin-binding proteins or PBPs) that are responsible for forming cross-links in the peptidoglycan layer of the bacterial cell wall. When the cell wall is weakened or improperly formed, the bacteria become unstable and eventually lyse (burst), leading to their death. Spectrum of Activity: Cefoperazone is effective against a broad range of bacteria, including many Gram-positive and Gram-negative organisms. Tazobactam (Beta-Lactamase Inhibitor): How it works: Many bacteria produce enzymes called beta-lactamases. These enzymes can break down and inactivate beta-lactam antibiotics like cefoperazone, rendering them ineffective. Tazobactam acts as a “shield” for cefoperazone. It binds to and inactivates these beta-lactamase enzymes. Synergistic Effect: By inhibiting the bacterial beta-lactamases, tazobactam “protects” cefoperazone, allowing cefoperazone to exert its antibacterial effect even against bacteria that would otherwise be resistant. This combination creates a synergistic effect, meaning the combined effect is greater than the sum of their individual effects. Why This Combination? The combination of cefoperazone and tazobactam is designed to: Broaden the Spectrum of Activity: Effectively treat infections caused by a wider range of bacteria, including those that produce beta-lactamases. Overcome Resistance: Provide an effective treatment option for infections caused by bacteria that have developed resistance to other antibiotics. Treat Serious Infections: Used for moderate to severe bacterial infections where the causative organism is suspected or confirmed to be susceptible. Indications (Common Uses): EFUBAC-TZ 1.125 INJECTION is typically indicated for the treatment of infections caused by susceptible organisms, including: Respiratory Tract Infections: Pneumonia, bronchitis. Urinary Tract Infections (UTIs): Including pyelonephritis. Skin and Soft Tissue Infections: Cellulitis, abscesses, impetigo. Intra-abdominal Infections: Peritonitis, cholecystitis. Biliary Tract Infections: Cholangitis. Septicemia (Bloodstream Infections). Bone and Joint Infections. Gynecological Infections: Pelvic inflammatory disease. Prophylaxis: Sometimes used to prevent infections before surgery. Administration: Route: This is an injectable medication, typically administered either intramuscularly (IM) or intravenously (IV). The route and dosage will depend on the type and severity of the infection, as well as the patient’s condition. Preparation: The powder is usually reconstituted with a specific diluent (e.g., sterile water for injection) before administration. Medical Supervision: This is a prescription-only medication and must be administered by a qualified healthcare professional. Medroots Biopharma Pvt Ltd’s Role: Marketing and Distribution: Medroots Biopharma Pvt Ltd is responsible for the marketing, sales, and distribution of EFUBAC-TZ 1.125 INJECTION. As a pharmaceutical company, they ensure the product meets quality standards and reaches healthcare providers and patients. Regulatory Compliance: They would be responsible for adhering to all regulatory requirements for the manufacturing and marketing of such a critical medication. Important Considerations and Warnings: Prescription Only: This medication should only be used under the strict supervision of a doctor. Allergies: Patients with known hypersensitivity to cephalosporins, penicillins, or beta-lactamase inhibitors should not use this drug. Allergic reactions can range from rash to severe anaphylaxis. Side Effects: Common side effects can include diarrhea, nausea, vomiting, abdominal pain, rash, itching, and pain at the injection site. More serious side effects, though less common, can occur and require immediate medical attention. Renal Impairment: Dosage adjustments may be necessary for patients with impaired kidney function. Pregnancy and Lactation: Use during pregnancy and breastfeeding should only be considered if the potential benefits outweigh the risks, and under medical advice